-
Product Insights
Cartilage Degeneration – Drugs In Development, 2023
Global Markets Direct’s, ‘Cartilage Degeneration - Drugs In Development, 2023’, provides an overview of the Cartilage Degeneration pipeline landscape. The report provides comprehensive information on the therapeutics under development for Cartilage Degeneration, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Sector Analysis
Cartilage Repair Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Cartilage Repair Market Report Overview The cartilage repair market size was $76.3 million in 2023. The market is expected to grow at a CAGR of less than 1% during 2023 and 2033. Cartilage repair procedures aim to regenerate, restore, or replace articular cartilage to reduce joint pain and prevent the development of arthritis. Cartilage Repair Market Outlook, 2023-2033 ($ Million) Buy Full Report for More Insights into The Cartilage Repair Market Forecast Download a Free Report Sample The cartilage repair...
-
Product Insights
NewLikelihood of Approval Analysis for Arthritis Pain
Overview How likely is it that the drugs in Arthritis Pain will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Arthritis Pain Overview Arthritis pain stems from inflammation in joints, causing discomfort,...
-
Product Insights
NewLikelihood of Approval Analysis for Osteoarthritis Pain
Overview How likely is it that the drugs in Osteoarthritis Pain will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Osteoarthritis Pain Overview Osteoarthritis pain, the hallmark symptom of this degenerative joint...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GNR-079 in Cartilage Degeneration
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. GNR-079 in Cartilage Degeneration Drug Details: GNR-079 is under development for the treatment of cartilage...
-
Sector Analysis
Arthroscopic Shavers Market Size by Segments, Share, Regulatory, Reimbursement, Procedures, Installed Base and Forecast to 2033
Arthroscopic Shavers Market Report Overview The Arthroscopic Shavers market size was $1.43 billion in 2023. The market is expected to grow at a CAGR of more than 4% during 2023-2033. Arthroscopic Shavers are powered systems used to scrape and cut tissues or bones to remove debris during arthroscopy surgeries. Defective cartilage and the inflamed inner lining of the joint are removed with the help of shavers. Arthroscopic Shavers Market Outlook, 2023-2033 ($ Billion) Buy Full Report for More Insights into...
-
Sector Analysis
Rheumatoid Arthritis (RA) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Reasons to buy the ‘Rheumatoid Arthritis (RA)’ marketed and pipeline drugs assessment report: Get a comprehensive overview of the rheumatoid arthritis market including disease epidemiology, treatment guidelines, clinical trials, deals, and an assessment of marketed and pipeline drugs. Get an insight into MoA, RoA, and molecule types for the leading marketed and pipeline drugs in RA. Assess the pricing and reimbursement of rheumatoid arthritis marketed and pipeline drugs. Get a detailed assessment of the clinical trials taking place within the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Remestemcel-L in Ulcerative Colitis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Remestemcel-L in Ulcerative Colitis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Remestemcel-L in Ulcerative Colitis Drug Details: Remestemcel-L (Prochymal, Temcell) is a stem...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – MPC-75IA in Pain
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - MPC-75IA in Pain report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.MPC-75IA in PainDrug Details:MPC-75-IA (MSB-CAR001) is under development for the treatment of knee osteoarthritis,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Xstem in Osteoarthritis Pain
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Xstem in Osteoarthritis Pain report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.XSTEM in Osteoarthritis Pain Drug Details:XSTEM is under development for the treatment of...